In their debut trading on Friday, October 30 Atea Pharmaceuticals, Inc. (AVIR) showed a 26.42% raise to close at $30.34 per share. Shortly before the company had placed its shares in an IPO priced $24 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей